君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01877 君实生物

已收盘 09-19 16:08:11

10.460

+0.560

+5.66%

最高10.760	最低10.000	成交量148.76万
今开10.040	昨收9.900	日振幅7.68%
总市值103.10亿	流通市值22.91亿	总股本9.86亿
成交额1,544万	换手率0.68%	流通股本2.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":10.46,"timestamp":1726733291002,"preClose":9.9,"halted":0,"volume":1487600,"delay":0,"floatShares":219000000,"shares":985689871,"eps":-2.5563874,"marketStatus":"已收盘","marketStatusCode":5,"change":0.56,"latestTime":"09-19 16:08:11","open":10.04,"high":10.76,"low":10,"amount":15438678,"amplitude":0.076768,"askPrice":10.52,"askSize":200,"bidPrice":10.46,"bidSize":1200,"shortable":3,"etf":0,"ttmEps":-2.162070257104564,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1726795800000},"adr":0,"listingDate":1545580800000,"adjPreClose":9.9,"openAndCloseTimeList":[[1726709400000,1726718400000],[1726722000000,1726732800000]],"volumeRatio":4.031849,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物","latestPrice":24.47,"timestamp":1726729200000,"preClose":24.33,"halted":0,"volume":4155262,"delay":0,"premium":"-61.21"}},"requestUrl":"/m/hq/s/01877","defaultTab":"news","newsList":[{"id":"2468592385","title":"君实生物(01877)上涨5.05%，报10.4元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2468592385","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468592385?lang=zh_cn&edition=full","pubTime":"2024-09-19 10:27","pubTimestamp":1726712830,"startTime":"0","endTime":"0","summary":"9月19日，君实生物(01877)盘中上涨5.05%，截至10:27，报10.4元/股，成交565.46万元。上海君实生物医药科技股份有限公司主要业务是发现、开发和商业化创新疗法，特别是在肿瘤免疫疗法、自身免疫系统疾病、慢性代谢类疾病、神经系统疾病、感染类疾病等治疗方面。公司拥有卓越的创新药物发现能力、先进的生物技术研发、全产业链大规模生产技术和极具市场潜力的在研药品组合。截至2024年中报，君实生物营业总收入7.86亿元、净利润-6.46亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/19102743345887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","BK1583","BK0239","688180","BK1515","01877"],"gpt_icon":0},{"id":"2468733352","title":"智通AH统计|9月17日","url":"https://stock-news.laohu8.com/highlight/detail?id=2468733352","media":"智通财经","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468733352?lang=zh_cn&edition=full","pubTime":"2024-09-17 16:15","pubTimestamp":1726560905,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止9月17日收盘，东北电气、弘业期货、浙江世宝分列AH溢价率前三位，溢价率分别为1173.58%、535.50%、505.88%；紫金矿业、福耀玻璃、招商银行分列AH溢价率末三位，溢价率分别为16.42%、21.24%、21.76%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183790.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02238","01339","06655","01658","06185","03678","HK0000320223.HKD","IE00BPRC5H50.USD","00995","002594","03347","06066","02218","BYDDY","03606","01055","06865","00042","LU1868837722.USD","01057","01456","01787","03968","02338","06690","00981","01349","LU1770034418.SGD","01211","SG9999006514.SGD","00914","01877","01330","159982","81211","00038","01375","01033","MARA","399300","BK1546","00553","03143","00187","LU1861214812.USD","02899","00895","03908"],"gpt_icon":1},{"id":"2467914788","title":"智通AH统计|9月16日","url":"https://stock-news.laohu8.com/highlight/detail?id=2467914788","media":"智通财经","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467914788?lang=zh_cn&edition=full","pubTime":"2024-09-16 16:15","pubTimestamp":1726474504,"startTime":"0","endTime":"0","summary":"智通财经APP数据显示，截止9月16日收盘，东北电气、弘业期货、浙江世宝分列AH溢价率前三位，溢价率分别为1173.58%、554.88%、500.00%；紫金矿业、福耀玻璃、招商银行分列AH溢价率末三位，溢价率分别为19.27%、22.62%、24.45%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1183549.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02238","01339","06655","LU0463099449.HKD","BK1171","01658","06680","06185","03678","00995","002594","03347","06066","02218","BYDDY","03606","01055","06865","00042","01057","01456","01787","03968","02338","06690","01919","01349","IE00BZ08YS42.EUR","UPST","01211","BK1537","00914","01877","01330","159982","81211","BK1214","01033","MARA","399300","02208","00553","03143","00187","02899","BKYI","BK1607","00323","BK1231","03908"],"gpt_icon":1},{"id":"2467899125","title":"君实生物(01877)下跌5.44%，报10.08元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2467899125","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467899125?lang=zh_cn&edition=full","pubTime":"2024-09-16 15:41","pubTimestamp":1726472461,"startTime":"0","endTime":"0","summary":"9月16日，君实生物(01877)盘中下跌5.44%，截至15:41，报10.08元/股，成交100.94万元。上海君实生物医药科技股份有限公司主要业务是发现、开发和商业化创新疗法，特别是在肿瘤免疫疗法、自身免疫系统疾病、慢性代谢类疾病、神经系统疾病、感染类疾病等治疗方面。公司拥有卓越的创新药物发现能力、先进的生物技术研发、全产业链大规模生产技术和极具市场潜力的在研药品组合。截至2024年中报，君实生物营业总收入7.86亿元、净利润-6.46亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/16154143307185.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688180","BK0239","BK1161","BK1515","BK1583","01877"],"gpt_icon":0},{"id":"2467537899","title":"君实生物盘中异动 临近收盘急速下跌5.25%报10.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467537899","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467537899?lang=zh_cn&edition=full","pubTime":"2024-09-16 15:30","pubTimestamp":1726471834,"startTime":"0","endTime":"0","summary":"2024年09月16日临近收盘15时30分，君实生物股票出现异动，股价大幅跳水5.25%。截至发稿，该股报10.100港元/股，成交量6.62万股，换手率0.03%，振幅3.00%。资金方面，该股资金流入19.4412万港元，流出45.0336万港元。君实生物股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，宜明昂科-B、歌礼制药-B、康方生物涨幅较大，振幅较大的相关个股有宜明昂科-B、帝王国际投资、歌礼制药-B，振幅分别为47.17%、25.81%、25.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240916153035a1da87c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240916153035a1da87c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688180","BK0239","01877"],"gpt_icon":0},{"id":"2466104469","title":"君实生物(01877)下跌5.12%，报10.38元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2466104469","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466104469?lang=zh_cn&edition=full","pubTime":"2024-09-10 14:54","pubTimestamp":1725951292,"startTime":"0","endTime":"0","summary":"9月10日，君实生物(01877)盘中下跌5.12%，截至14:54，报10.38元/股，成交961.68万元。上海君实生物医药科技股份有限公司主要业务是发现、开发和商业化创新疗法，特别是在肿瘤免疫疗法、自身免疫系统疾病、慢性代谢类疾病、神经系统疾病、感染类疾病等治疗方面。公司拥有卓越的创新药物发现能力、先进的生物技术研发、全产业链大规模生产技术和极具市场潜力的在研药品组合。截至2024年中报，君实生物营业总收入7.86亿元、净利润-6.46亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/09/10145443143350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01877","688180","BK1515","BK1583","BK0239","BK1161"],"gpt_icon":0},{"id":"2466315495","title":"君实生物(01877)：股份回购计划实施完毕 累计回购股份81.59万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2466315495","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466315495?lang=zh_cn&edition=full","pubTime":"2024-09-09 17:43","pubTimestamp":1725874997,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物(01877)发布公告，截至本公告披露日，公司本次股份回购计划实施完毕。公司通过上海证券交易所系统以集中竞价交易方式累计回购股份81.59万股，占公司总股本的0.0828%，回购成交的最高价为人民币41.69元/股，最低价为人民币29.03元/股，回购均价为人民币37.85元/股，支付的资金总额为人民币3088.32万元(不含印花税、交易佣金等费用)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1180866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688180","BK1583","01877","BK1515","BK1161"],"gpt_icon":0},{"id":"2466115823","title":"港股收评：港股主要股指低开低走 石油、煤炭股下挫","url":"https://stock-news.laohu8.com/highlight/detail?id=2466115823","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466115823?lang=zh_cn&edition=full","pubTime":"2024-09-09 16:18","pubTimestamp":1725869913,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["00883","HHImain","IAU","09866","399441","80883","LU0871576103.HKD","GDX","LU0531971595.HKD","NUGT","159938","DUST","07226","513600","GCmain","01877","LU0561508036.HKD","HSImain","00857","02833","603259","MGCmain","BK0239","02269","MHImain","HSCEI","HSTECH","02359","688180","SGCmain","BK1589","MCHmain","LU0516423174.USD","00386","00702","SGUmain","HSI","161032","GLD","159934","LU2488822045.USD","LU1634259391.SGD","LU1961090484.USD","161726","09939","518880","159831","YANG"],"gpt_icon":0},{"id":"2465554844","title":"【机构调研记录】鹏华基金调研君实生物、海目星等5只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2465554844","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465554844?lang=zh_cn&edition=full","pubTime":"2024-09-05 08:02","pubTimestamp":1725494570,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月4日披露的机构调研信息，鹏华基金近期对5家上市公司进行了调研，相关名单如下：1）君实生物 个股亮点：H股:君实生物于2018-12-24上市；公司创新药PD-1成功落地；公司位于上海市浦东新区自由贸易试验区海趣路36、58号2号楼13层，主营业务为新药的研发及相关技术的转让和服务，新药的生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090500006322.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK0239","BK1161","BK1515","688559","688180","BK0251","BK1583"],"gpt_icon":0},{"id":"2465316554","title":"【机构调研记录】长盛基金调研君实生物、希荻微等6只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2465316554","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465316554?lang=zh_cn&edition=full","pubTime":"2024-09-05 08:02","pubTimestamp":1725494569,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月4日披露的机构调研信息，长盛基金近期对6家上市公司进行了调研，相关名单如下：1）君实生物 个股亮点：H股:君实生物于2018-12-24上市；公司创新药PD-1成功落地；公司位于上海市浦东新区自由贸易试验区海趣路36、58号2号楼13层，主营业务为新药的研发及相关技术的转让和服务，新药的生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090500006321.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1583","BK0231","BK0239","688173","688180","BK1515","01877"],"gpt_icon":0},{"id":"2465873554","title":"【机构调研记录】国金基金调研君实生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2465873554","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465873554?lang=zh_cn&edition=full","pubTime":"2024-09-05 08:01","pubTimestamp":1725494517,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月4日披露的机构调研信息，国金基金近期对1家上市公司进行了调研，相关名单如下：1）君实生物 个股亮点：H股:君实生物于2018-12-24上市；公司创新药PD-1成功落地；公司位于上海市浦东新区自由贸易试验区海趣路36、58号2号楼13层，主营业务为新药的研发及相关技术的转让和服务，新药的生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090500006248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688180","BK1583","01877","BK1515","BK1161"],"gpt_icon":0},{"id":"2465543975","title":"【机构调研记录】同泰基金调研君实生物","url":"https://stock-news.laohu8.com/highlight/detail?id=2465543975","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465543975?lang=zh_cn&edition=full","pubTime":"2024-09-05 08:01","pubTimestamp":1725494507,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月4日披露的机构调研信息，同泰基金近期对1家上市公司进行了调研，相关名单如下：1）君实生物 个股亮点：H股:君实生物于2018-12-24上市；公司创新药PD-1成功落地；公司位于上海市浦东新区自由贸易试验区海趣路36、58号2号楼13层，主营业务为新药的研发及相关技术的转让和服务，新药的生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090500006237.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","01877","BK1161","BK1515","BK1583","688180"],"gpt_icon":0},{"id":"2465554303","title":"【机构调研记录】博远基金调研君实生物、高华科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2465554303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465554303?lang=zh_cn&edition=full","pubTime":"2024-09-05 08:01","pubTimestamp":1725494506,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月4日披露的机构调研信息，博远基金近期对2家上市公司进行了调研，相关名单如下：1）君实生物 个股亮点：H股:君实生物于2018-12-24上市；公司创新药PD-1成功落地；公司位于上海市浦东新区自由贸易试验区海趣路36、58号2号楼13层，主营业务为新药的研发及相关技术的转让和服务，新药的生产和销售。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090500006236.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","BK1515","688539","01877","BK1583","688180","BK0239","BK0214"],"gpt_icon":0},{"id":"2464329421","title":"君实生物：9月1日召开业绩说明会，方正证券、国金基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2464329421","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464329421?lang=zh_cn&edition=full","pubTime":"2024-09-04 17:45","pubTimestamp":1725443146,"startTime":"0","endTime":"0","summary":"2023年11月，JUSTR-001研究成功召开全球启动会，正式启动该研究 项目。EC将把CHMP的积极意见纳入考虑，以便对 特瑞普利单抗的上市许可申请做出最终审评决议。根据公司已披露的公告，除美国外，特瑞普利单抗的上市申请已获得欧盟、英国、新加 坡、澳大利亚等地药监部门受理。已累计在全国超过五千家 医疗机构及超过两千家专业药房及社会药房销售。此外，苏州吴江生产基地已顺利通过EM现场核查，并于2024年7月收","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090400031012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","BK0122","BK0012","BK0188","01877","BK0028","688180","601901","BK1515","BK0239","BK1161","BK1583","BK0276"],"gpt_icon":0},{"id":"2464328512","title":"君实生物业绩继续亏损，37亿定增资金被套牢","url":"https://stock-news.laohu8.com/highlight/detail?id=2464328512","media":"读创客户端","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464328512?lang=zh_cn&edition=full","pubTime":"2024-09-04 16:29","pubTimestamp":1725438547,"startTime":"0","endTime":"0","summary":"财中社 曾智/文君实生物尚未盈利过，2024年上半年亏损6.45亿元。公司目前股价相比之前的定增价已腰斩，37.77亿元定增资金被套牢。8月31日，君实生物发布2024年中期报告，公司实现营业收入7.86亿元，同比增加17.37%；净利润亏损虽然同比缩窄35.34%，但亏损额依然高达6.45亿元。《财中社》查询发现，业绩亏损的原因是营收无法覆盖开支。根据《财中社》统计，包括上述定增在内，君实生物通过AH两个市场募资金额142.98亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090416412895e161e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090416412895e161e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688180","BK0239","01877"],"gpt_icon":0},{"id":"2464605013","title":"太平洋给予君实生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2464605013","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464605013?lang=zh_cn&edition=full","pubTime":"2024-09-04 08:50","pubTimestamp":1725411014,"startTime":"0","endTime":"0","summary":"太平洋09月04日发布研报称，给予君实生物（688180.SH，最新价：24.84元）买入评级。评级理由主要包括：1）2024H1拓益销售收入大幅增长，公司整体运营效率持续提升，亏损收窄；2）2024年拓益国内医保适应症有望扩至10项，国际化布局进展顺；3）利，多项核心管线稳步推进；4）2024年拓益国内销售保持高速增长，海外在更多地区上市，后期；5）核心管线催化剂丰富。风险提示：研发或销售不及预期风险，行业政策风险。文章来源：每日经济新闻原标题：太平洋给予君实生物买入评级","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409040859189edde6d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409040859189edde6d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01877","688180","601099"],"gpt_icon":0},{"id":"2464241815","title":"港股创新药ETF（159567）涨近1%，科伦博泰生物-B、君实生物涨超2%，机构：创新依然是药品行业最强的驱动之一丨ETF观察","url":"https://stock-news.laohu8.com/highlight/detail?id=2464241815","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464241815?lang=zh_cn&edition=full","pubTime":"2024-09-03 10:13","pubTimestamp":1725329580,"startTime":"0","endTime":"0","summary":"截至发稿，港股通创新药指数涨超0.3%，成分股中，科伦博泰生物-B、君实生物涨超2%，荣昌生物、和黄医药、云顶新耀-B、凯莱英、康希诺生物、圣诺医药-B等多股涨超1%。相关ETF方面，紧密跟踪港股通创新药指数的港股创新药ETF截至发稿上涨0.94%，成交额超2000万元，换手率达13%，盘中交投活跃。Wind数据显示，该ETF昨日获资金净流入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090310185195dd8b50&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090310185195dd8b50&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688180","01877","06990","BK1161","BK1515","BK1583","LU0196878994.USD"],"gpt_icon":0},{"id":"2464578968","title":"君实生物(01877.HK)累计回购81.58万A股  涉资3,088万人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2464578968","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464578968?lang=zh_cn&edition=full","pubTime":"2024-09-03 01:29","pubTimestamp":1725298140,"startTime":"0","endTime":"0","summary":"君实生物(01877.HK) 公布，8月底止，累计回购81.58万股A股，占公司总股本0.0828%；每股作价介乎29.03-41.69元人民币，资金总额约3,088万人民币。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-09-02 16:25。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190121165959803_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190121165959803_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1378545/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["688180","399300","BK1515","BK1161","BK0239","01877","BK1583","159982"],"gpt_icon":0},{"id":"2464887334","title":"君实生物(01877)累计回购股份81.59万股A股 耗资3088.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2464887334","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464887334?lang=zh_cn&edition=full","pubTime":"2024-09-02 18:31","pubTimestamp":1725273097,"startTime":"0","endTime":"0","summary":"智通财经APP讯，君实生物(01877)发布公告，截至2024年8月31日，公司通过上海证券交易所交易系统以集中竞价交易方式已累计回购股份81.59万股，占公司总股本比例为0.0828%，回购成交的最高价为人民币41.69元/股，最低价为人民币29.03元/股，支付的资金总额为人民币3088.32万元(不含印花税、交易佣金等交易费用)。本次回购股份进展符合法律法规的规定及公司回购股份方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178188.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","01877","688180","399300","BK0239","159982","BK1515","BK1161"],"gpt_icon":0},{"id":"2464788901","title":"君实生物：累计回购约82万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2464788901","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464788901?lang=zh_cn&edition=full","pubTime":"2024-09-02 17:35","pubTimestamp":1725269718,"startTime":"0","endTime":"0","summary":"每经AI快讯，君实生物 9月2日晚间发布公告称，截至2024年8月31日，公司通过上海证券交易所交易系统以集中竞价交易方式已累计回购股份约82万股，占公司总股本比例为0.0828%，回购成交的最高价为人民币41.69元/股，最低价为人民币29.03元/股，支付的资金总额为人民币约3088万元。2023年1至12月份，君实生物的营业收入构成为：医药制造业占比98.11%。截至发稿，君实生物市值为243亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090217395295db91a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024090217395295db91a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688180","01877"],"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":-0.0499},{"period":"1month","weight":-0.1509},{"period":"3month","weight":-0.1653},{"period":"6month","weight":-0.0678},{"period":"1year","weight":-0.4923},{"period":"ytd","weight":-0.4907}],"compareEarnings":[{"period":"1week","weight":0.0247},{"period":"1month","weight":0.0132},{"period":"3month","weight":-0.0418},{"period":"6month","weight":0.0473},{"period":"1year","weight":-0.0151},{"period":"ytd","weight":0.0359}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物科技有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.122873},{"month":2,"riseRate":0.833333,"avgChangeRate":0.02917},{"month":3,"riseRate":0.666667,"avgChangeRate":0.049114},{"month":4,"riseRate":0.833333,"avgChangeRate":0.112597},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.034116},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.02585},{"month":7,"riseRate":0.5,"avgChangeRate":-0.055172},{"month":8,"riseRate":0,"avgChangeRate":-0.083168},{"month":9,"riseRate":0,"avgChangeRate":-0.108956},{"month":10,"riseRate":0.4,"avgChangeRate":0.053036},{"month":11,"riseRate":0.6,"avgChangeRate":0.067975},{"month":12,"riseRate":0.8,"avgChangeRate":0.175695}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.4","shortVersion":"4.26.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}